APO RESEARCH · REPORT
Artificial Heart Lung Machines
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Product & engineering
Understand the product.
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Selected research
Market Analysis & Forecast
Global Artificial Heart Lung Machines Market Analysis and Forecast 2026-2032
Market perspective
Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Global Artificial Heart Lung Machines key players include LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, etc. Global top five manufacturers hold a share about 95%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Single Roller Pump HLM is the largest segment, with a share about 60%. And in terms of application, the largest application is Cardiac Surgery, followed by Lung Transplant Operation, Acute Respiratory Failure Treatment, etc.
This report presents an overview of global market for Artificial Heart Lung Machines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
Read the full market overview
This report researches the key producers of Artificial Heart Lung Machines, also provides the sales of main regions and countries. Of the upcoming market potential for Artificial Heart Lung Machines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Heart Lung Machines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artificial Heart Lung Machines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Artificial Heart Lung Machines sales, projected growth trends, production technology, application and end-user industry.
Artificial Heart Lung Machines Segment by Company
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Artificial Heart Lung Machines Segment by Type
Single Roller Pump HLM
Double Roller Pump HLM
Artificial Heart Lung Machines Segment by Application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
Artificial Heart Lung Machines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Heart Lung Machines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Heart Lung Machines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Heart Lung Machines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Artificial Heart Lung Machines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Artificial Heart Lung Machines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Heart Lung Machines sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Roller Pump HLM
- Double Roller Pump HLM
Applications
- Cardiac Surgery
- Lung Transplant Operation
- Acute Respiratory Failure Treatment
- Others
Companies covered
- LivaNova (Sorin)
- Getinge (Maquet)
- Medtronic
- Terumo CV Group
- Braile Biomedica
- Tianjin Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Artificial Heart Lung Machines Market by Type
- 1.2.1 Global Artificial Heart Lung Machines Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Single Roller Pump HLM
- 1.2.3 Double Roller Pump HLM
- 1.3 Artificial Heart Lung Machines Market by Application
- 1.3.1 Global Artificial Heart Lung Machines Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Cardiac Surgery
- 1.3.3 Lung Transplant Operation
- 1.3.4 Acute Respiratory Failure Treatment
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Artificial Heart Lung Machines Market Dynamics
- 2.1 Artificial Heart Lung Machines Industry Trends
- 2.2 Artificial Heart Lung Machines Industry Drivers
- 2.3 Artificial Heart Lung Machines Industry Opportunities and Challenges
- 2.4 Artificial Heart Lung Machines Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Artificial Heart Lung Machines Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Artificial Heart Lung Machines Revenue by Region
- 3.2.1 Global Artificial Heart Lung Machines Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Artificial Heart Lung Machines Revenue by Region (2021-2026)
- 3.2.3 Global Artificial Heart Lung Machines Revenue by Region (2027-2032)
- 3.2.4 Global Artificial Heart Lung Machines Revenue Market Share by Region (2021-2032)
- 3.3 Global Artificial Heart Lung Machines Sales Estimates and Forecasts 2021-2032
- 3.4 Global Artificial Heart Lung Machines Sales by Region
- 3.4.1 Global Artificial Heart Lung Machines Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Artificial Heart Lung Machines Sales by Region (2021-2026)
- 3.4.3 Global Artificial Heart Lung Machines Sales by Region (2027-2032)
- 3.4.4 Global Artificial Heart Lung Machines Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Artificial Heart Lung Machines Revenue by Manufacturers
- 4.1.1 Global Artificial Heart Lung Machines Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Artificial Heart Lung Machines Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Artificial Heart Lung Machines Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Artificial Heart Lung Machines Sales by Manufacturers
- 4.2.1 Global Artificial Heart Lung Machines Sales by Manufacturers (2021-2026)
- 4.2.2 Global Artificial Heart Lung Machines Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Artificial Heart Lung Machines Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Artificial Heart Lung Machines Sales Price by Manufacturers (2021-2026)
- 4.4 Global Artificial Heart Lung Machines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Artificial Heart Lung Machines Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Artificial Heart Lung Machines Manufacturers, Product Type & Application
- 4.7 Global Artificial Heart Lung Machines Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Artificial Heart Lung Machines Market CR5 and HHI
- 4.8.2 2025 Artificial Heart Lung Machines Tier 1, Tier 2, and Tier 3
5 Artificial Heart Lung Machines Market by Type
- 5.1 Global Artificial Heart Lung Machines Revenue by Type
- 5.1.1 Global Artificial Heart Lung Machines Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Artificial Heart Lung Machines Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Artificial Heart Lung Machines Revenue Market Share by Type (2021-2032)
- 5.2 Global Artificial Heart Lung Machines Sales by Type
- 5.2.1 Global Artificial Heart Lung Machines Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Artificial Heart Lung Machines Sales by Type (2021-2032) & (Units)
- 5.2.3 Global Artificial Heart Lung Machines Sales Market Share by Type (2021-2032)
- 5.3 Global Artificial Heart Lung Machines Price by Type
6 Artificial Heart Lung Machines Market by Application
- 6.1 Global Artificial Heart Lung Machines Revenue by Application
- 6.1.1 Global Artificial Heart Lung Machines Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Artificial Heart Lung Machines Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Artificial Heart Lung Machines Revenue Market Share by Application (2021-2032)
- 6.2 Global Artificial Heart Lung Machines Sales by Application
- 6.2.1 Global Artificial Heart Lung Machines Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Artificial Heart Lung Machines Sales by Application (2021-2032) & (Units)
- 6.2.3 Global Artificial Heart Lung Machines Sales Market Share by Application (2021-2032)
- 6.3 Global Artificial Heart Lung Machines Price by Application
7 Company Profiles
- 7.1 LivaNova (Sorin)
- 7.1.1 LivaNova (Sorin) Company Information
- 7.1.2 LivaNova (Sorin) Business Overview
- 7.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 LivaNova (Sorin) Artificial Heart Lung Machines Product Portfolio
- 7.1.5 LivaNova (Sorin) Recent Developments
- 7.2 Getinge (Maquet)
- 7.2.1 Getinge (Maquet) Company Information
- 7.2.2 Getinge (Maquet) Business Overview
- 7.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Getinge (Maquet) Artificial Heart Lung Machines Product Portfolio
- 7.2.5 Getinge (Maquet) Recent Developments
- 7.3 Medtronic
- 7.3.1 Medtronic Company Information
- 7.3.2 Medtronic Business Overview
- 7.3.3 Medtronic Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Medtronic Artificial Heart Lung Machines Product Portfolio
- 7.3.5 Medtronic Recent Developments
- 7.4 Terumo CV Group
- 7.4.1 Terumo CV Group Company Information
- 7.4.2 Terumo CV Group Business Overview
- 7.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Terumo CV Group Artificial Heart Lung Machines Product Portfolio
- 7.4.5 Terumo CV Group Recent Developments
- 7.5 Braile Biomedica
- 7.5.1 Braile Biomedica Company Information
- 7.5.2 Braile Biomedica Business Overview
- 7.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Braile Biomedica Artificial Heart Lung Machines Product Portfolio
- 7.5.5 Braile Biomedica Recent Developments
- 7.6 Tianjin Medical
- 7.6.1 Tianjin Medical Company Information
- 7.6.2 Tianjin Medical Business Overview
- 7.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Tianjin Medical Artificial Heart Lung Machines Product Portfolio
- 7.6.5 Tianjin Medical Recent Developments
8 North America
- 8.1 North America Artificial Heart Lung Machines Market Size by Type
- 8.1.1 North America Artificial Heart Lung Machines Revenue by Type (2021-2032)
- 8.1.2 North America Artificial Heart Lung Machines Sales by Type (2021-2032)
- 8.1.3 North America Artificial Heart Lung Machines Price by Type (2021-2032)
- 8.2 North America Artificial Heart Lung Machines Market Size by Application
- 8.2.1 North America Artificial Heart Lung Machines Revenue by Application (2021-2032)
- 8.2.2 North America Artificial Heart Lung Machines Sales by Application (2021-2032)
- 8.2.3 North America Artificial Heart Lung Machines Price by Application (2021-2032)
- 8.3 North America Artificial Heart Lung Machines Market Size by Country
- 8.3.1 North America Artificial Heart Lung Machines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Artificial Heart Lung Machines Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Artificial Heart Lung Machines Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Artificial Heart Lung Machines Market Size by Type
- 9.1.1 Europe Artificial Heart Lung Machines Revenue by Type (2021-2032)
- 9.1.2 Europe Artificial Heart Lung Machines Sales by Type (2021-2032)
- 9.1.3 Europe Artificial Heart Lung Machines Price by Type (2021-2032)
- 9.2 Europe Artificial Heart Lung Machines Market Size by Application
- 9.2.1 Europe Artificial Heart Lung Machines Revenue by Application (2021-2032)
- 9.2.2 Europe Artificial Heart Lung Machines Sales by Application (2021-2032)
- 9.2.3 Europe Artificial Heart Lung Machines Price by Application (2021-2032)
- 9.3 Europe Artificial Heart Lung Machines Market Size by Country
- 9.3.1 Europe Artificial Heart Lung Machines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Artificial Heart Lung Machines Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Artificial Heart Lung Machines Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Artificial Heart Lung Machines Market Size by Type
- 10.1.1 China Artificial Heart Lung Machines Revenue by Type (2021-2032)
- 10.1.2 China Artificial Heart Lung Machines Sales by Type (2021-2032)
- 10.1.3 China Artificial Heart Lung Machines Price by Type (2021-2032)
- 10.2 China Artificial Heart Lung Machines Market Size by Application
- 10.2.1 China Artificial Heart Lung Machines Revenue by Application (2021-2032)
- 10.2.2 China Artificial Heart Lung Machines Sales by Application (2021-2032)
- 10.2.3 China Artificial Heart Lung Machines Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Artificial Heart Lung Machines Market Size by Type
- 11.1.1 Asia Artificial Heart Lung Machines Revenue by Type (2021-2032)
- 11.1.2 Asia Artificial Heart Lung Machines Sales by Type (2021-2032)
- 11.1.3 Asia Artificial Heart Lung Machines Price by Type (2021-2032)
- 11.2 Asia Artificial Heart Lung Machines Market Size by Application
- 11.2.1 Asia Artificial Heart Lung Machines Revenue by Application (2021-2032)
- 11.2.2 Asia Artificial Heart Lung Machines Sales by Application (2021-2032)
- 11.2.3 Asia Artificial Heart Lung Machines Price by Application (2021-2032)
- 11.3 Asia Artificial Heart Lung Machines Market Size by Country
- 11.3.1 Asia Artificial Heart Lung Machines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Artificial Heart Lung Machines Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Artificial Heart Lung Machines Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Artificial Heart Lung Machines Market Size by Type
- 12.1.1 SAMEA Artificial Heart Lung Machines Revenue by Type (2021-2032)
- 12.1.2 SAMEA Artificial Heart Lung Machines Sales by Type (2021-2032)
- 12.1.3 SAMEA Artificial Heart Lung Machines Price by Type (2021-2032)
- 12.2 SAMEA Artificial Heart Lung Machines Market Size by Application
- 12.2.1 SAMEA Artificial Heart Lung Machines Revenue by Application (2021-2032)
- 12.2.2 SAMEA Artificial Heart Lung Machines Sales by Application (2021-2032)
- 12.2.3 SAMEA Artificial Heart Lung Machines Price by Application (2021-2032)
- 12.3 SAMEA Artificial Heart Lung Machines Market Size by Country
- 12.3.1 SAMEA Artificial Heart Lung Machines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Artificial Heart Lung Machines Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Artificial Heart Lung Machines Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Artificial Heart Lung Machines Value Chain Analysis
- 13.1.1 Artificial Heart Lung Machines Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Artificial Heart Lung Machines Production Mode & Process
- 13.2 Artificial Heart Lung Machines Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Artificial Heart Lung Machines Distributors
- 13.2.3 Artificial Heart Lung Machines Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst